It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Patients with heart failure and reduced ejection fraction (HF-REF) treated with an investigational angiotensin receptor neprilysin Inhibitor (ARNI) are more likely to reduce cardiovascular death and heart failure hospitalization than...
Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual.

LATEST
Ebola clinical activity speeds up ...

The Ebola outbreak has taught us that the health systems in West Africa are under-resourced and vulnerable. Scaling up ...

FDA: Keep boxed warning on Chantix
Unprecedented efficacy of latest ...
[BLOG]: Providers and payers share ...
Public-private partnerships in ...

FDA APPROVALS
FDA approves Obizur for acquired ...

FDA has approved Antihemophilic Factor (Recombinant), Porcine Sequence] (Obizur, Baxter) for the treatment of bleeding ...

FDA approves abuse-deterrent ...
FDA approves bortezomib for ...
FDA approves antiemetic agent for ...

CLINICAL
FDA approves Obizur for acquired ...

FDA has approved Antihemophilic Factor (Recombinant), Porcine Sequence] (Obizur, Baxter) for the treatment of bleeding ...

Ebola clinical activity speeds up ...
FDA approves abuse-deterrent ...
FDA: Keep boxed warning on Chantix

DRUGS IN PERSPECTIVE
Drug Overview: Zykadia (ceritinib)

Zykadia (ceritinib) is a tyrosine kinase inhibitor that was approved by FDA on April 29, 2014, as a medication for the ...

Drugs in Perspective: Dalvance
Drug Overview: Tasimelteon (Hetlioz)
Drug Overview: Aptiom ...

Latest Tweets Follow